Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2026-02-28 @ 10:52 PM
Study NCT ID:
NCT01462266
Status:
COMPLETED
Last Update Posted:
2018-08-17
First Post:
2011-10-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2013-06-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-27
First Submit QC Date:
None
Study First Post Date:
2011-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-01-08
Results First Submit QC Date:
None
Results First Post Date:
2014-04-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-20
Last Update Post Date:
2018-08-17
Last Update Post Date Type:
ACTUAL